| 12/31/2010 | HYLM | Clearwater Paper gets tenders for nearly all Cellu Tissue 111/2% notes
|
| 12/31/2010 | BKHY | S&P lifts Cellu Tissue
|
| 12/13/2010 | HYLM | Clearwater Paper prices tender offer for Cellu Tissue's 111/2% notes
|
| 12/7/2010 | HYLM | Clearwater Paper extends tender offer for Cellu Tissue's 111/2% notes
|
| 11/22/2010 | HYLM | Clearwater Paper extends early tender date for Cellu Tissue 111/2% notes
|
| 11/5/2010 | HYLM | Clearwater Paper tenders for Cellu Tissue's 111/2% notes due 2014
|
| 10/12/2010 | HY | Market Commentary: Primary slate builds with Omnova, Sino-Forest deals; Fortescue hops while J.C. Penney flops
|
| 10/12/2010 | HY | Clearwater Paper expected to price $350 million eight-year deal mid-week, will have call protection
|
| 9/20/2010 | BKHY | Moody's: Cellu Tissue acquired, debt retired
|
| 9/17/2010 | BKHY | S&P reviews Clearwater, Cellu Tissue
|
| 9/16/2010 | HYLM | Cellu Tissue announces plans to tender for or defease 111/2% notes
|
| 4/28/2010 | HYLM | Cellu Tissue bought back some 111/2% notes via $29 million IPO proceeds
|
| 1/7/2010 | HY | Moody's upgrades Cellu Tissue
|
| 12/23/2009 | BKHY | S&P upgrades Cellu
|
| 10/16/2009 | HY | Cellu Tissue plans to buy back some 111/2% notes via IPO proceeds
|
| 6/9/2009 | HY | Moody's: Cellu Tissue notes unaffected
|
| 5/27/2009 | HY | Market Commentary: American Tower, Harrah's, AMC price, deal lifts existing Harrah's; Verso, Virgin, Terex slate
|
| 5/22/2009 | HY | Market Commentary: GMAC gains, ResCap rolls on bailout bucks; primary placid after torrid week, lull in trading
|
| 5/21/2009 | HY | Market Commentary: Apria leads six-deal, $2.44 billion day; GMAC, Quiksilver up again; funds gain $368 million
|
| 5/20/2009 | HY | Market Commentary: MarkWest, Hughes price; market awaits Gibson, upsized Apria; GMAC up on aid talk, Hertz gains
|
| 5/19/2009 | HY | New Issue: Cellu Tissue upsizes to $255 million, prices 111/2% notes at 96.368 to yield 121/2%
|
| 5/19/2009 | HY | Market Commentary: WMG, Ashland lead as deal barrage goes on; Bio-Rad, Ashland up; numbers lift Pilgrim's Pride
|
| 5/18/2009 | HY | Market Commentary: Upsized Scientific Games prices, Apria could bring second deal; new Sealy, MGM stay above par
|
| 5/18/2009 | HY | Cellu Tissue talks $230 million notes at 121/2% area with a discount
|
| 5/15/2009 | HY | Market Commentary: Sealy prices as surprise 'sleeper' deal; Regency brings deal too; First Data falls on numbers
|
| 5/13/2009 | BKHY | Moody's: Cellu Tissue view positive, rates notes B2
|
| 5/13/2009 | BKHY | S&P rates Cellu Tissue notes B
|
| 5/13/2009 | HY | Market Commentary: MGM up on financing news; Wyndham prices bonds, others slate; Frontier firms on Verizon deal
|
| 5/12/2009 | HY | Market Commentary: Upsized Calpine, Linn price; Cellu Tissue, Gibson slate deals; Lear lifted, Sprint struggles
|
| 5/12/2009 | HY | Cellu Tissue roadshowing $230 million secured notes via JP Morgan
|
| 7/10/2008 | BKHY | S&P affirms Cellu Tissue
|
| 7/9/2008 | BKHY | Moody's rates Cellu Tissue's notes B2
|
| 7/8/2008 | HY | New Issue: Cellu Tissue sells $40 million 93/4% notes in private placement
|
| 7/7/2008 | BKHY | S&P: Cellu Tissue unchanged
|
| 3/13/2008 | BKHY | S&P rates Cellu Tissue notes 4
|
| 3/27/2007 | HY | New Issue: Cellu Tissue Holdings sells $20.26 million 93/4% notes to Wingate Capital
|
| 3/1/2007 | HY | Cellu Tissue plans bond sale to help fund merger with CityForest
|
| 9/22/2006 | BKHY | Moody's introduces new ratings
|
| 6/5/2006 | HY | Cellu Tissue gets required consents for 93/4% notes
|
| 5/24/2006 | HY | Cellu Tissue ups payment, extends consent solicitation for 93/4% notes
|
| 11/8/2005 | BKHY | Moody's ups Cellu Tissue outlook to stable
|
| 10/12/2005 | BKHY | S&P affirms Cellu Tissue at B
|
| 10/7/2005 | HY | Market Commentary: Delphi dives on renewed bankruptcy fears; Cellu-Tissue off as acquisition scrubbed
|
| 9/2/2005 | HY | S&P: Cellu Tissue still on positive watch
|
| 6/17/2005 | HY | Moody's: Cellu view developing
|
| 6/16/2005 | HY | S&P affirms Cellu Tissue, Thilmany
|
| 6/15/2005 | HY | Cellu Tissue acquisition to trigger change-of-control put
|
| 3/5/2004 | HY | Market Commentary: Trinity, seven more deals price; Tyco firmer as top charge dropped
|
| 3/5/2004 | HY | New Issue: Cellu Tissue sells $162 million six-year notes to yield 10%
|
| 3/4/2004 | HY | Cellu Tissue $160 million six-year notes talked 93/4-10%, to price Friday
|
| 3/4/2004 | HY | Moody's rates Cellu Tissue notes B2
|
| 3/4/2004 | HY | Market Commentary: Station Casinos brings upsized quickie deal; Bally stabilizes; funds see $135 million inflow
|
| 3/2/2004 | HY | S&P rates Cellu Tissue notes B
|
| 2/25/2004 | HY | Cellu Tissue starts roadshow for $160 million six-year notes
|
| 2/25/2004 | HY | Market Commentary: Nortek floaters, iStar preferreds price; Adelphia gyrates as plan filed
|
